To access this element change to forms mode OFF
Grant Award View - GA187371
RADAR: A randomised PET-adapted study of bleomycin-free treatment of...
GA ID:
GA187371
Agency:
Department of Health and Aged Care
Approval Date:
9-Jun-2021
Publish Date:
30-Aug-2021
Category:
Health and Medical Research
Grant Term:
9-Jun-2021 to 31-May-2026
Value (AUD):
$1,395,463.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 20/21 1.1 Health Policy Research and Analysis
Grant Program:
2020_MRFF ICTC Round 2_2021
Grant Activity:
RADAR: A randomised PET-adapted study of bleomycin-free treatment of early stage Hodgkin Lymphoma
Purpose:
RADAR is a phase III randomised trial in patients with untreated, early stage Hodgkin Lymphoma. It will test if bleomycin (B) can be replaced by an antibody treatment called brentuximab vedotin (A) combined with the standard chemotherapy 'AVD'. Patients with an early complete response on PET scan will need fewer total chemotherapy cycles and no radiotherapy, reducing toxicity of treatment including future heart disease and secondary cancer while maintaining excellent control of the lymphoma.
GO ID:
GO Title:
MRFF Clinical Trial Activity Initiative - 2020 International Clinical Trial Collaborations Grant Opportunity
Internal Reference ID:
MRF2008063
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Sydney
Recipient ABN:
15 211 513 464
Grant Recipient Location
Suburb:
Camperdown
Town/City:
Camperdown
Postcode:
2050
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, VIC, QLD, TAS
Postcode:
Multiple
Country:
AUSTRALIA